Prevention of nosocomial bacterial pneumonia

Thorax

Volumn 54, Issue 6, 1999, Pages 544-549

  Vincent, Jean Louis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL IMMUNITY; BACTERIAL PNEUMONIA; HOSPITAL INFECTION; INFECTION PREVENTION; PRIORITY JOURNAL; REVIEW;

EID: 0033048566     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.6.544     Document Type: Review

References (82)

1. 1 Chevret S, Hemmer M, Carlet J, et al. Incidence and risk factors of pneumonia acquired in intensive care units. Intensive Care Med 1993;19:256-64.
2. 2 Dreyfuss D, Djedaini K, Weber P, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis 1991; 143:738-41.
3. 3 Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator associated pneumonia in determining patient mortality. Chest 1995;108:1655-62.
4. 4 Sirvent JM, Torres A, El-Ebiary M, et al. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 1997;155:1729-34.
5. 5 Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866-9.
6. 6 Kropec A, Schulgen G, Just H, et al. Scoring systems for nosocomial pneumonia in ICUs. Intensive Care Med 1996; 22:1155-61.
7. 7 Vincent JL, Bihari D, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: the results of the EPIC study. JAMA 1995;274:639-44.
8. 8 Wiener J, Itokazu G, Nathan C, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis 1995;20:861-7.
9. 9 Albert S, Kirchner J, Thomas H, et al. Role of quantitative cultures and microscopic examinations of endotracheal aspirates in the diagnosis of pulmonary infections in ventilated patients. J Hosp Infect 1997;37:25-37.
10. 10 Marsh B, Hone R, White M, et al. European Nosocomial Infection Survey: analysis of Irish data. Ir Med J 1996;89:96-8.
11. 11 Denys D, Martens P, Mullie A, et al. Incidence of nosocomial pneumonia in ICU patients. Acta Anaesthesiol Belg 1993;44:111-8.
12. 12 Rello J, Quintana E, Ausina V, et al. Incidence, etiology and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991;100:439-44.
13. 13 Rello J, Ausina V, Ricart M, et al. Nosocomial pneumonia in critically ill comatose patients: need for a differential therapeutic approach. Eur Respir J 1992;5:1249-53.
14. 14 Joshi N, Localio AR, Hamory BH. A predictive risk index for nosocomial pneumonia in the intensive care unit. Am J Med 1992;93:135-42.
15. 15 Rello J, Ausina V, Castella J, et al. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest 1992;102:525-9.
16. 16 Nielsen SL, Roder B, Magnussen P, et al. Nosocomial pneumonia in an intensive care unit in a Danish university hospital: incidence, mortality and etiology. Scand J Infect Dis 1992;24:65-70.
17. 17 Torres A, Aznar R, Gatell JM, et al. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990;142:523-8.
18. 18 Craven DE, Kunches LM, Lichtenberg DA, et al. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988;148:1161-8.
19. 19 Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:231-8.
20. 20 Leu HS, Kaiser DL, Mori M, et al. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 1989;129:1258-67.
21. 21 Kappstein I, Schulgen G, Beyer U, et al. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504-8.
22. 22 Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343-9.
23. 23 Kollef MM. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993;270:1965-70.
24. 24 Bonten MJ, Gaillard CA, van Tiel FH, et al. The stomach is not a source for colonization of the upper respiratory tract and pneumonia in ICU patients. Crit Care Med 1994;105: 878-84.
25. 25 Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992;101:458-63.
26. 26 Geddes DM. Infection versus colonisation. Intensive Care Med 1990;16:S201-5
27. 27 Sanchez-Nieto JM, Torres A, Arcia-Cordoba F, et al. Impact of invasive and non-invasive quantitative culture sampling on outcome of ventilator-associated pneumonia. Am J Respir Crit Care Med 1998;157:371-6.
28. 28 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy and preventative strategies. Am J Respir Crit Care Med 1995;153:1711-25.
29. 29 Fagon JY, Chastre J. Diagnosis of nosocomial pneumonia in intensive care unit patients. Curr Opin Crit Care 1997;3: 363-9.
30. 30 Cassiere HA, Niederman MS. New etiopathogenic concepts of ventilator-associated pneumonia. Semin Respir Infect 1996;11:13-23.
31. 31 Niederman MS. Gram-negative colonisation of the respiratory tract: pathogenesis and clinical consequences. Semin Respir Infect 1990;5:173-84.
32. 32 Steere AC, Mallison GF. Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975; 83:683-90.
33. 33 Graham M. Frequency and duration of hand washing in an intensive care unit. Am J Infect Control 1990;18:77-81.
34. 34 Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88-93.
35. 35 Crowe M, Towner KJ, Humphreys H. Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit. J Med Microbiol 1995;43:55-62.
36. 36 Long MN, Wickstrom G, Grimes A, et al. Prospective, randomized study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week. Infect Control Hosp Epidemiol 1996;17:14-9.
37. 37 Deppe SA, Kelly JW, Thoi LL, et al. Incidence of colonization, nosocomial pneumonia and mortality in critically ill patients using a Trach Care closed-suction system versus an open-suction: prospective, randomized study. Crit Care Med 1990;18:1389-93.
38. 38 Kirton OC, DeHaven BMJ, Morejon O, et al. A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early onset (community acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion. Chest 1997;112:1055-9.
39. 39 Cohen IL, Weinberg PF, Fein IA, et al. ET tube occlusion associated with the use of heat and moisture exchangers in the intensive care unit. Crit Care Med 1988;16:277-9.
40. 40 Martin C, Perrin G, Gevaudan M, et al. Heat and moisture exchangers and vaporizing humidifiers in the ICU. Chest 1990;97:144-9.
41. 41 Abele-Horn M, Dauber A, Bauernfeind A, et al. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination. Intensive Care Med 1997; 23:187-95.
42. 42 Vandenbroucke-Grauls CM, Vandenbroucke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 1991;338:859-62.
43. 43 Rogers CJ, van Saene HK, Suter P, et al. Infection control in critically ill patients: effects of selective contamination of the digestive tract. Am J Hosp Pharmacol 1994;51:631-48.
44. 44 Cockerill FRI, Muller SR, Ahnalt JP, et al. Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med 1992;117:545-53.
45. 45 Hammond JM, Potgieter PD, Saunders GL, et al. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992;340:5-9.
46. 46 D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998;316: 1275-85.
47. 47 Nardi G, Valentinis U, Proietti A, et al. Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. Intensive Care Med 1993;19:273-8.
48. 48 Kollef MH, Ward S. The influence of mini-BAL cultures on patients outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113: 412-20.
49. 49 Apte NM, Karnad DR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med 1992;20:590-3.
50. 50 Martin LF, Booth FV, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993;21:19-30.
51. 51 Metz CA, Livingston DH, Smith JS, et al. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. Crit Care Med 1993;21:1844-9.
52. 52 Conk DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients. JAMA 1996;275:308-14.
53. 2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991;19:942-9.
54. 54 Cook DJ, Laine LA, Guyatt GH, et al. Nosocomial pneumonia and the role of gastric pH. A meta-analysis. Chest 1991;100:7-13.
55. 55 Bonten MJ, Gaillard CA, van der Geest S, et al. The role of intragastric acidity and stress ulcer prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am J Respir Crit Care Med 1995; 152:1825-34.
56. 56 Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive-care unit. A randomized, controlled, single-blind study. Ann Intern Med 1994;121:568-75.
57. 57 Thomason MH, Payseur ES, Hakenewerth AM, et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid and ranitidine. J Trauma 1996;41:503-8.
58. 58 Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998;338:791-7.
59. 59 Sinuff T, Cook DJ. Nosocomial sinusitis: a critical appraisal of the evidence. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Heidelberg: Springer-Verlag, 1998: 292-9.
60. 60 Holzapfel L, Chevret S, Madinier G, et al. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit Care Med 1993;21:1132-8.
61. 61 Torres A, Gatell JM, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995;152:137-41.
62. 62 Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions and stress ulcer prophylaxis. Intensive Care Med 1992;18:20-5.
63. 63 Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995;122:179-86.
64. 64 Inglis TJ, Sherratt MJ, Sproat LJ, et al. Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet 1993:341:911-3.
65. 65 Vallés J. Severe pneumonia: sources of infection and implications for treatment. Sepsis 1998;1:199-209.
66. 66 Montecalvo MA, Steger KA, Farber HW, et al. Nutritional outcome and pneumonia in critical care patients rand omized to gastric versus jejunal tube feedings. Crit Care Med 1992;20:1377-87.
67. 67 Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988;93:318-24.
68. 68 Torres A, Serra-Battles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992;116:540-3.
69. 69 Whiteman K, Nachtmann L, Kramer D, et al. Effects of continuous lateral rotation therapy on pulmonary complications in liver transplant patients. Am J Crit Care 1995;4: 133-9.
70. 70 Cook D, De Jonghe B, Brochard L, et al. Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. JAMA 1998;279:781-7.
71. 71 Gennari R, Alexander JW. Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis. Crit Care Med 1997;25:1207-14.
72. 72 Fayon MJ, Tucci M, Lacroix J, et al. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. Am J Respir Crit Care Med 1997;155:162-9.
73. 73 Hanson LC, Weber DJ, Rutala WA, et al. Risk Factors for nosocomial pneumonia in the elderly. Am J Med 1992;92: 161-6.
74. 74 Heyland DK, Cook DJ, Guyatt GH. Enteral nutrition in the critically ill patient: a critical review of the evidence. Intensive Care Med 1993;19:435-42.
75. 75 Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995;23:436-49.
76. 76 Docke WD, Randow F, Syrbe HP, et al. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nature Med 1997;3:678-81.
77. 77 Dries DJ, Jurkovich GJ, Maier RV, et al. Effect of Interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch Surg 1994;129:1031-41.
78. 78 Wasserman D, Ioannovish JD, Hinzmann RD, et al. Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. Crit Care Med 1998;26:434-9.
79. 79 Beck JM, Liggitt HD, Brunette EN, et al. Reduction of intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immunol 1991;59:3859-62.
80. 80 Greenberger MJ, Kunkel SL, Strieter RM, et al. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 1996;157:3006-12.
81. 81 Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994;84:1737-46.
82. 82 Heard SO, Fink MP, Gamelli RL, et al. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. Crit Care Med 1998;26:748-54.